BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16240454)

  • 41. Valproic acid induces neuroendocrine differentiation and UGT2B7 up-regulation in human prostate carcinoma cell line.
    Valentini A; Biancolella M; Amati F; Gravina P; Miano R; Chillemi G; Farcomeni A; Bueno S; Vespasiani G; Desideri A; Federici G; Novelli G; Bernardini S
    Drug Metab Dispos; 2007 Jun; 35(6):968-72. PubMed ID: 17371798
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Mechanism of inhibiting the proliferation of prostate cancer by finasteride: a study using cDNA microarray].
    Chen G; Geng J; Zhang YF
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1489-92. PubMed ID: 16061029
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generation of active TGF-beta by prostatic cell cocultures using novel basal and luminal prostatic epithelial cell lines.
    Salm SN; Koikawa Y; Ogilvie V; Tsujimura A; Coetzee S; Moscatelli D; Moore E; Lepor H; Shapiro E; Sun TT; Wilson EL
    J Cell Physiol; 2000 Jul; 184(1):70-9. PubMed ID: 10825235
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells.
    Sells SF; Wood DP; Joshi-Barve SS; Muthukumar S; Jacob RJ; Crist SA; Humphreys S; Rangnekar VM
    Cell Growth Differ; 1994 Apr; 5(4):457-66. PubMed ID: 8043520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostate androgen-regulated gene: a novel potential target for androgen-independent prostate cancer therapy.
    Xu XF; Zhou SW; Zhang X; Ye ZQ; Zhang JH; Ma X; Zheng T; Li HZ
    Asian J Androl; 2006 Jul; 8(4):455-62. PubMed ID: 16763722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prosaposin upregulates AR and PSA expression and activity in prostate cancer cells (LNCaP).
    Koochekpour S; Lee TJ; Wang R; Culig Z; Delorme N; Caffey S; Marrero L; Aguirre J
    Prostate; 2007 Feb; 67(2):178-89. PubMed ID: 17044040
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
    Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
    Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Steroid receptors in prostate cancer tissues and cells: pathophysiology, problems in methodology, clinical value and controversial questions.
    Pavone-Macaluso M; Carruba G; Castagnetta L
    Arch Esp Urol; 1994 Mar; 47(2):189-201. PubMed ID: 8002681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Castration rapidly decreases local insulin-like growth factor-1 levels and inhibits its effects in the ventral prostate in mice.
    Ohlson N; Bergh A; Persson ML; Wikström P
    Prostate; 2006 Dec; 66(16):1687-97. PubMed ID: 16998818
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conversion of prostate cancer from hormone independency to dependency due to AMACR inhibition: involvement of increased AR expression and decreased IGF1 expression.
    Takahara K; Azuma H; Sakamoto T; Kiyama S; Inamoto T; Ibuki N; Nishida T; Nomi H; Ubai T; Segawa N; Katsuoka Y
    Anticancer Res; 2009 Jul; 29(7):2497-505. PubMed ID: 19596919
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.
    Migliaccio A; Di Domenico M; Castoria G; Nanayakkara M; Lombardi M; de Falco A; Bilancio A; Varricchio L; Ciociola A; Auricchio F
    Cancer Res; 2005 Nov; 65(22):10585-93. PubMed ID: 16288052
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hic-5/ARA55, a LIM domain-containing nuclear receptor coactivator expressed in prostate stromal cells.
    Heitzer MD; DeFranco DB
    Cancer Res; 2006 Jul; 66(14):7326-33. PubMed ID: 16849583
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PTOV1: a novel testosterone-induced atherogenic gene in human aorta.
    Nakamura Y; Suzuki T; Igarashi K; Kanno J; Furukawa T; Tazawa C; Fujishima F; Miura I; Ando T; Moriyama N; Moriya T; Saito H; Yamada S; Sasano H
    J Pathol; 2006 Aug; 209(4):522-31. PubMed ID: 16639697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Purine-rich element binding protein (PUR) alpha induces endoplasmic reticulum stress response, and cell differentiation pathways in prostate cancer cells.
    Inoue T; Maeno A; Talbot C; Zeng Y; Yeater DB; Leman ES; Kulkarni P; Ogawa O; Getzenberg RH
    Prostate; 2009 Jun; 69(8):861-73. PubMed ID: 19267365
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppression of androgen receptor expression by dibenzoylmethane as a therapeutic objective in advanced prostate cancer.
    Jackson KM; Frazier MC; Harris WB
    Anticancer Res; 2007; 27(3B):1483-8. PubMed ID: 17595765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.
    Banham AH; Boddy J; Launchbury R; Han C; Turley H; Malone PR; Harris AL; Fox SB
    Prostate; 2007 Jul; 67(10):1091-8. PubMed ID: 17477366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.
    Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW
    Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuroprotective gene expression profiles in ischemic cortical cultures preconditioned with IGF-1 or bFGF.
    Yoshida E; Atkinson TG; Chakravarthy B
    Brain Res Mol Brain Res; 2004 Nov; 131(1-2):33-50. PubMed ID: 15530650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin receptor substrate 1 modulates the transcriptional activity and the stability of androgen receptor in breast cancer cells.
    Lanzino M; Garofalo C; Morelli C; Le Pera M; Casaburi I; McPhaul MJ; Surmacz E; Andò S; Sisci D
    Breast Cancer Res Treat; 2009 May; 115(2):297-306. PubMed ID: 18521741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular regulation of androgen action in prostate cancer.
    Dehm SM; Tindall DJ
    J Cell Biochem; 2006 Oct; 99(2):333-44. PubMed ID: 16518832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.